623 related articles for article (PubMed ID: 16112611)
1. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
Myrmel H; Navaratnam V; Asjø B
J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
[TBL] [Abstract][Full Text] [Related]
2. [Hepatitis C virus screening: performances characteristics of a commercial automated chemiluminescent microparticle immunoassay (CMIA-ARCHITECT anti-HCV)].
Petitjean Lecherbonnier J; Gouarin S; Dina J; Vabret A; Freymuth F
Pathol Biol (Paris); 2007 Dec; 55(10):512-20. PubMed ID: 17959324
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of a modified version of the ARCHITECT Anti-HCV test in detecting samples with immunoblot-confirmed, low-level antibody to hepatitis C virus.
Echevarría JM; Avellón A; Jonas G; Hausmann M; Vockel A; Kapprell HP
J Clin Virol; 2006 Apr; 35(4):368-72. PubMed ID: 16406797
[TBL] [Abstract][Full Text] [Related]
4. Performance characteristics of the ARCHITECT anti-HCV assay.
Jonas G; Pelzer C; Beckert C; Hausmann M; Kapprell HP
J Clin Virol; 2005 Oct; 34(2):97-103. PubMed ID: 16122974
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions.
Berger A; Rabenau H; Allwinn R; Doerr HW
J Clin Virol; 2008 Oct; 43(2):158-61. PubMed ID: 18635393
[TBL] [Abstract][Full Text] [Related]
6. [Low positive anti-HCV microparticle enzyme immunoassay results: do they predict hepatitis C virus infection?].
Sayan M; Meriç M; Mutlu B; Celebi S; Willke A
Mikrobiyol Bul; 2006; 40(1-2):81-4. PubMed ID: 16775961
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the patients with low levels of anti-HCV positivity].
Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
[TBL] [Abstract][Full Text] [Related]
9. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.
Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G
J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility and characteristics of nine anti-HCV antibody screening reagents used in Japan.
Kita M; Deguchi M; Kagita M; Yoshioka N; Kobayashi E; Watanabe M; Asari S; Yamanaka K; Iwatani Y
Clin Lab; 2009; 55(1-2):9-22. PubMed ID: 19350845
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China.
Wu S; Liu Y; Cheng L; Yin B; Peng J; Sun Z
J Med Virol; 2011 Nov; 83(11):1930-7. PubMed ID: 21915868
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ
J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955
[TBL] [Abstract][Full Text] [Related]
13. Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test.
Huang WS; Lu SN; Wang JH; Lee CM; Tung HD; Chen TM; ChangChien CS
Hepatogastroenterology; 2005; 52(63):893-6. PubMed ID: 15966227
[TBL] [Abstract][Full Text] [Related]
14. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the performance of the EIAgen HCV test for detection of hepatitis C virus infection.
Rao HY; Ren FR; Guan WL; Houde M; Du SC; Liu CL; Gong XY; Wei L
J Virol Methods; 2009 Dec; 162(1-2):203-7. PubMed ID: 19703491
[TBL] [Abstract][Full Text] [Related]
16. Limits of diagnostic accuracy of anti-hepatitis C virus antibodies detection by ELISA and immunoblot assay.
Suslov AP; Kuzin SN; Golosova TV; Shalunova NV; Malyshev NA; Sadikova NV; Vavilova LM; Somova AV; Musina EE; Ivanova MV; Kipor TT; Timonin IM; Kuzina LE; Godkov MA; Bajenov AI; Nesterenko VG
Russ J Immunol; 2002 Jul; 7(2):175-84. PubMed ID: 12687261
[TBL] [Abstract][Full Text] [Related]
17. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
[TBL] [Abstract][Full Text] [Related]
18. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
[TBL] [Abstract][Full Text] [Related]
19. Application of the Serodia-HCV particle agglutination for the detection of antibodies to hepatitis C virus.
Ooi BG; Sinniah M; Ismail S; Baharuddin R
Malays J Pathol; 1996 Dec; 18(2):89-93. PubMed ID: 10879228
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of three commercially available hepatitis C virus antibody detection assays under the conditions of a clinical virology laboratory.
Zachary P; Ullmann M; Djeddi S; Meyer N; Wendling MJ; Schvoerer E; Stoll-Keller F; Gut JP
J Clin Virol; 2005 Nov; 34(3):207-10; discussion 216-8. PubMed ID: 16122975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
